J&J’s One-Dose COVID-19 Vaccine Shows 72% Efficacy in the US
Results from Phase 3 clinical trials on Johnson & Johnson’s (J&J) one-dose COVID-19 vaccine demonstrated 72% effectiveness against moderate to severe COVID-19-related illness in the United States. However, this rate dropped to 57%…